Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Topsun Science And Technology Co Ltd Announces Capital Injection in Subsidiary


Friday, 21 Jun 2013 08:00pm EDT 

Topsun Science And Technology Co Ltd announced that Mr. Lu Qiang will inject RMB 12 million in a subsidiary of the Company, which is engaged in production and sales of drugs, as well as purchase of agricultural and sideline products, as well as commissary. As a result, Mr. Lu will hold a 59.70% stake in the subsidiary, up from 0%. The Company will hold a 39.80% stake in the subsidiary, down from 98.77%. 

Company Quote